Enhanced lung fibrosis in protein C inhibitor transgenic mice Source: Eur Respir J 2004; 24: Suppl. 48, 481s Year: 2004
A T cell-specific inhibitor of NF-kappaB and AP-1 suppresses lung fibrosis in mice Source: Eur Respir J 2004; 24: Suppl. 48, 101s Year: 2004
Suppression of discoidin domain receptor 1 by RNA interference attenuates lung inflammation Source: Annual Congress 2006 - Cellular immunology in asthma pathogenesis Year: 2006
Prolyl-3-hydroxylase 4 (P3H4), a novel player in collagen synthesis and secretion in lung fibroblasts Source: Virtual Congress 2021 – Translational and other aspects of idiopathic interstitial pneumonia Year: 2021
Alveolar type 2 cell dysfunction from expression of a surfactant protein C (SFTPC) mutation drives a fibrotic lung phenotype in mice Source: International Congress 2017 – Cellular signalling pathways in pulmonary fibrosis Year: 2017
Vascular remodeling in the lung from mice treated with monocrotaline. The effect of protein C inhibitor transgenic expression Source: Eur Respir J 2006; 28: Suppl. 50, 823s Year: 2006
Thrombin induces stomatin-like protein 2 (STOML2) expression and IL-8/CXCL8 release by ROCK, JNK, and PEA3 pathways in human lung epithelial cells Source: Virtual Congress 2020 – Asthma science: novel targets and mechanisms Year: 2020
Expression of the nuclear factor-?B inhibitor A20 is altered in the cystic fibrosis epithelium Source: Eur Respir J 2013; 41: 1315-1323 Year: 2013
LATE-BREAKING ABSTRACT: PI3K p110γ is overexpressed in IPF lung tissue and fibroblast cells. In vitro effects of its inhibition Source: Annual Congress 2012 - Lung injury and repair: reactive oxygen species and beyond Year: 2012
Inhibition of B7-H4 gene expression by RNA interference (RNAi) in lung cancer A549 cell line Source: Annual Congress 2011 - Progress in pathology of lung cancer Year: 2011
Apoptosis regulatory protein (p53, Bcl-2, survivin) expression in lung cancer-preliminary study Source: Annual Congress 2008 - Novel trends in functional genomics and molecular pathology of neoplastic and non-neoplastic lung diseases Year: 2008
Erythropoietin (EPO) attenuates the immunohistochemical expression of autophagy antibodies in bleomycin (BLM), induced pulmonary fibrosis (PF) in rats Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis Year: 2019
Fas Ligand (FasL) expressed on alveolar lymphocytes (AL) plays role in progression of interstitial lung diseases (ILD) but not in local induction of immune cells apoptosis Source: Eur Respir J 2005; 26: Suppl. 49, 542s Year: 2005
Increased expression of microRNA-146a negatively regulates both the LPS and Poly (I:C) induced inflammatory response in monocytes Source: Annual Congress 2010 - Macrophages: cell biology and disease-specific characteristics Year: 2010
Caspase recruitment domain containing protein 9 suppresses non-small cell lung cancer proliferation and invasion via inhibiting MAPK/p38 pathway Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer Year: 2020
TGFβ induced myofibroblast differentiation is independent of p38 activation, but requires TGFβR1 kinase activity and correlates with TGFβ-mediated SMAD signaling and TGFβ-responsive gene expression patterns in human lung fibroblasts Source: Eur Respir J 2004; 24: Suppl. 48, 718s Year: 2004
Hepatocyte growth factor (HGF) expression in bronchoveolar lower (BAL) does not confirm its anti-fibrotic activity in interstitial lung diseases (ILD) Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis Year: 2012
Proapoptotic and anti-proliferative effect of the stable plasminogen activator inhibitor type 1 (PAI-1) mutant on the lung cancer and endothelial cells Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease? Year: 2009
Microarrays reveal coordinated expression of ADAMs family of genes in an in vitro model of pulmonary fibrosis Source: Annual Congress 2005 - Progresses in lung fibrosis Year: 2005
Inhibitor of DNA-binding (Id) – 1 and 3 proteins overexpression has impact on prognosis of lung adenocarcinoma Source: Annual Congress 2011 - Progress in pathology of lung cancer Year: 2011